{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2029982", "DateCompleted": {"Year": "1991", "Month": "06", "Day": "19"}, "DateRevised": {"Year": "2006", "Month": "11", "Day": "15"}, "Article": {"Language": ["ger"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0015-8178", "JournalIssue": {"Volume": "109", "Issue": "4", "PubDate": {"Year": "1991", "Month": "Feb", "Day": "10"}}, "Title": "Fortschritte der Medizin", "ISOAbbreviation": "Fortschr Med"}, "ArticleTitle": "[Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490].", "Pagination": {"StartPage": "119", "EndPage": "122", "MedlinePgn": "119-22"}, "Abstract": {"AbstractText": ["Within the framework of a randomized, placebo-controlled double-blind study, two groups each containing 20 patients with climacteric-related symptomatology were treated for a period of 8 weeks with kava WS 1490 extract 3 X 100 mg/day or a placebo preparation. The target variable - the HAMA overall score of anxiety symptomatology - revealed a significant difference in the drug-receiving group vis-\u00e0-vis the placebo group already after only 1 week of treatment. The course of such further parameters as depressive mood (DSI), subjective well-being (patient diary), severity of the disease (CGI), and the climacteric symptomatology (Kuppermann Index and Schneider scale) over the overall period of treatment demonstrate a high level of efficacy of kava extract WS 1490 in neurovegetative and psychosomatic dysfunctions in the climacteric, associated with very good tolerance of the preparation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gyn\u00e4kologe, Wuppertal."}], "LastName": "Warnecke", "ForeName": "G", "Initials": "G"}], "PublicationTypeList": ["Clinical Trial", "English Abstract", "Journal Article", "Randomized Controlled Trial"], "VernacularTitle": "Psychosomatische Dysfunktionen im weiblichen Klimakterium. Klinische Wirksamkeit und Vertr\u00e4glichkeit von Kava-Extrakt WS 1490."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Fortschr Med", "NlmUniqueID": "2984763R", "ISSNLinking": "0015-8178"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Climacteric"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Kava"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy", "psychology"], "DescriptorName": "Psychophysiologic Disorders"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1991", "Month": "2", "Day": "10"}, {"Year": "1991", "Month": "2", "Day": "10", "Hour": "0", "Minute": "1"}, {"Year": "1991", "Month": "2", "Day": "10", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2029982"]}}]}